Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,975.00
-35.00 (-0.87%)
At close: Aug 14, 2025, 3:30 PM KST
-0.87%
Market Cap110.02B
Revenue (ttm)108.14B
Net Income (ttm)1.41B
Shares Out27.68M
EPS (ttm)60.34
PE Ratio65.88
Forward PEn/a
Dividend30.00 (0.75%)
Ex-Dividend DateMar 4, 2025
Volume1,138,494
Average Volume3,208,781
Open4,010.00
Previous Close4,010.00
Day's Range3,950.00 - 4,155.00
52-Week Range2,995.00 - 5,580.00
Beta0.47
RSI56.21
Earnings Daten/a

About Hyundai Pharmaceutical

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally. The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive sy... [Read more]

Sector Healthcare
Founded 1965
Employees 393
Stock Exchange Korea Stock Exchange
Ticker Symbol 004310
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.